StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Took over 2 hrs

<< Previous

Bullboard Posts

Next >>

Comment by gojotv!on Jan 05, 2022 12:05pm

141 Views

Post# 34285517

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Took over 2 hrs

Then why is the answer "no" to the question "Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?"
Reading is fundamental.

LithLover wrote:

They did on Nov 26. This is just the SEC official filing of the recent private placement.

gojotv! wrote: If this is true, doesn't the company have to issue a news release? This would be material.

Nailbiter1 wrote: https://www.sec.gov/Archives/edgar/data/0001454263/000145426322000001/xslFormDX01/primary_doc.xml